367 related articles for article (PubMed ID: 28527370)
21. [Effects of carbon disulfide inhalation on lipid levels of ApoE gene knockout mice and C57BL/6J mice].
Liu J; Ni C; Ding L; Wang S; Qiao S; Cao J; Zhong L; Zhu B
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Nov; 32(11):844-7. PubMed ID: 25579033
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
23. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites.
Meng Q; Ma M; Zhang W; Bi Y; Cheng P; Yu X; Fu Y; Chao Y; Ji T; Li J; Chen Q; Zhang Q; Li Y; Shan J; Bian H
Gut Microbes; 2021; 13(1):1-27. PubMed ID: 33691599
[TBL] [Abstract][Full Text] [Related]
24. Dengyinnaotong attenuates atherosclerotic lesions, gut dysbiosis and intestinal epithelial barrier impairment in the high fat diet-fed ApoE
Xiong M; Zhang Z; Cui J; Du X; Chen Y; Zhang T
J Ethnopharmacol; 2024 Jan; 318(Pt A):116916. PubMed ID: 37453620
[TBL] [Abstract][Full Text] [Related]
25. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
[TBL] [Abstract][Full Text] [Related]
26. Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity.
Schreyer SA; Lystig TC; Vick CM; LeBoeuf RC
Atherosclerosis; 2003 Nov; 171(1):49-55. PubMed ID: 14642405
[TBL] [Abstract][Full Text] [Related]
27. PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice.
Torisu K; Zhang X; Nonaka M; Kaji T; Tsuchimoto D; Kajitani K; Sakumi K; Torisu T; Chida K; Sueishi K; Kubo M; Hata J; Kitazono T; Kiyohara Y; Nakabeppu Y
Genes Cells; 2016 Oct; 21(10):1030-1048. PubMed ID: 27545963
[TBL] [Abstract][Full Text] [Related]
28. Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice.
Zhou J; Werstuck GH; Lhoták S; Shi YY; Tedesco V; Trigatti B; Dickhout J; Majors AK; DiBello PM; Jacobsen DW; Austin RC
FASEB J; 2008 Jul; 22(7):2569-78. PubMed ID: 18364397
[TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy.
Ding S; Jiang J; Yu P; Zhang G; Zhang G; Liu X
PLoS One; 2017; 12(8):e0181666. PubMed ID: 28777810
[TBL] [Abstract][Full Text] [Related]
30. Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.
Hanh NT; Nhung BT; Dao DT; Tuyet LT; Hop LT; Binh TQ; Thuc VT
Lipids Health Dis; 2016 Oct; 15(1):176. PubMed ID: 27724906
[TBL] [Abstract][Full Text] [Related]
31. Experimental models of murine atherosclerosis: does perception match reality?
Johnston JM; Francis SE; Kiss-Toth E
Cardiovasc Res; 2018 Dec; 114(14):1845-1847. PubMed ID: 29878146
[No Abstract] [Full Text] [Related]
32. Prediction model for different progressions of Atherosclerosis in ApoE
Wang H; Zhang L; Zhang X; Song J; Guo Q; Zhang X; Bai D
J Pharm Biomed Anal; 2022 May; 214():114734. PubMed ID: 35378366
[TBL] [Abstract][Full Text] [Related]
33. Effects of apolipoprotein M in uremic atherosclerosis.
Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
[TBL] [Abstract][Full Text] [Related]
34. Soyasaponins A
Xie Q; Xiong F; Wu X; Chen J; Gu X; Su C; Xiao L; Zheng Z; Wei Y; Ullah H; Zha L
Food Funct; 2020 Jan; 11(1):253-269. PubMed ID: 31956875
[TBL] [Abstract][Full Text] [Related]
35. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
36. YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E
Chen L; Zheng J; Xue Q; Zhao Y
Heart Vessels; 2019 Nov; 34(11):1874-1881. PubMed ID: 31114961
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
38. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
[TBL] [Abstract][Full Text] [Related]
39. Untargeted Lipidomic Profiling Reveals Lysophosphatidylcholine and Ceramide as Atherosclerotic Risk Factors in
Law SH; Chan HC; Ke GM; Kamatam S; Marathe GK; Ponnusamy VK; Ke LY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108120
[TBL] [Abstract][Full Text] [Related]
40. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM
Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
